Olivier Petricoul Selected Research

Olivier Petricoul Research Topics

4	Obesity 01/2023 - 01/2018
3	Sarcopenia 10/2020 - 09/2017
2	Insulin Resistance 01/2021 - 01/2018
1	COVID-19 06/2023
1	Multiple Sclerosis 06/2023
1	Severe Acute Respiratory Syndrome 06/2023
1	Disease Progression 06/2023
1	Overweight 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Wasting Syndrome (Wasting Disease) 10/2020
1	Fatigue 01/2019
1	X-Linked Bulbo-Spinal Atrophy 12/2018
1	Neuromuscular Diseases (Neuromuscular Disease) 12/2018
1	Body Weight (Weight, Body) 01/2018
1	Mobility Limitation (Difficulty Walking) 09/2017
1	Acne Vulgaris 09/2017
1	Diarrhea 09/2017
1	Migraine Disorders (Migraine) 01/2002

6	bimagrumabIBA 01/2023 - 09/2017
2	Monoclonal AntibodiesIBA 01/2023 - 01/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 06/2023
1	siponimodIBA 06/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 06/2023
1	Activins (Activin)IBA 01/2023
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Anabolic AgentsIBA 10/2020
1	ianalumabIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 12/2018
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 01/2002
1	Sumatriptan (Imigran)FDA LinkGeneric 01/2002

1	Critical Care (Surgical Intensive Care) 06/2023
1	Glycemic Control 01/2021